封面
市場調查報告書
商品編碼
1575779

全球營養保健品市場 - 2024-2031

Global Nutraceuticals Market - 2024-2031

出版日期: | 出版商: DataM Intelligence | 英文 224 Pages | 商品交期: 最快1-2個工作天內

價格

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

報告概述

2023年,全球營養保健品市場規模達4,431億美元,預估至2031年將達6,842億美元,2024-2031年預測期間複合年成長率為5.58%。

消費者對健康生活方式益處的認知不斷提高,導致對保健補充劑的需求增加,特別是在注重健康的老齡化人群中。與生活方式相關的慢性病發病率的上升也強調了透過飲食選擇進行預防性護理的必要性。此外,電子商務的發展使消費者更容易獲得營養保健品,從而方便了他們的購買。

隨著基於個人遺傳和生活方式因素的個人化營養、對永續性的高度關注以及產品開發的持續創新等趨勢,市場有望進一步擴大。例如,2024 年 7 月,Renewtra 作為印度營養保健品行業的新品牌推出,旨在透過其經過臨床驗證的透明標籤產品徹底改變市場。

美國糖尿病和肥胖症的高發生率推動了北美在全球營養保健品市場的主導地位。大約有 3730 萬美國人患有糖尿病,超過 41.9% 的成年人屬於肥胖人群,因此對補充劑和功能性食品的需求不斷成長。隨著注重健康的消費者尋求有效的解決方案,北美仍然是營養保健品產業的領導者。

市場動態

慢性病的增加

肥胖、糖尿病和心血管疾病 (CVD) 的驚人成長正在極大地推動全球營養保健品市場的發展。超過 10 億人受到肥胖影響,5.37 億成年人患有糖尿病,有效管理解決方案的緊迫性從未如此明顯。消費者擴大尋求源自食物的營養保健品,這些產品對健康有益,有助於預防或控制這些慢性病。

預防性健康措施的轉變反映了人們對飲食與疾病之間關鍵聯繫的認知不斷增強,促使人們探索增強福祉的自然選擇。此外,由於對慢性病盛行率的擔憂,消費者健康意識不斷增強,正在推動營養保健品市場向前發展。

創新的監管批准和增強的配方

全球營養保健品市場由創新的法規核准和改進的配方推動。 2022 年11 月,Geno 推出了Avela 天然(R)-1,3-丁二醇,它提供了一種無糖成分,可以提高BETA-羥基丁酸水平,增強思維清晰度和運動表現,而無需限制飲食。 Avela 透過永續發酵從植物糖中提取,符合消費者對天然產品日益成長的需求。

此外,監管部門的批准,例如歐盟委員會於 2023 年 10 月對卡波姆聚合物的認可,使得能夠創造出創新的、更易於吞嚥的配方。這些進步共同滿足了不同消費者的需求和偏好,推動了功能性食品的發展,並為營養保健品市場的持續成長奠定了基礎。

多樣化的監管框架

由於監管框架多樣化,全球營養保健品市場面臨重大限制。每個國家都有自己的分類標準,考慮到一個地區對另一個地區的不同產品認知。這種不一致使合規性變得複雜,迫使公司分配時間和資源來應對各種法規。此外,某些領域嚴格的行銷準則限制了可以做出的健康聲明,從而阻礙了公司吸引消費者的能力。

細分市場分析

全球營養保健品市場根據類型、產品、來源、配銷通路、應用和地區進行細分。

雜交種子的卓越性能和產量潛力

從來源來看,植物性細分市場在全球營養保健品市場中佔據主導地位。這主要是由於消費者對天然和有機產品的需求不斷增加,以及人們對植物源成分的健康益處的認知不斷增強。此外,素食和純素食飲食的趨勢也促進了植物性營養保健品的流行。

純素食者人數不斷增加,預計到 2022 年將達到 8,800 萬左右,這對植物性營養保健品的受歡迎程度產生了重大影響。隨著越來越多的人採用素食和純素飲食,對不含動物成分的產品的需求不斷成長。這一趨勢正在推動植物性產業的創新和擴張,推動細分市場的成長。

市場地域佔有率

北美人口健康意識不斷增強

北美主導全球營養保健品市場。消費者對健康的高層次意識有力地支持了北美在全球市場的領導地位。 2023 年 CRN 膳食補充劑消費者調查顯示,74% 的美國成年人服用膳食補充劑,其中 55% 屬於經常使用者。這項重大採用增強了補充劑在美國人日常健康中的重要作用。

廣泛的使用反映了對預防性健康措施的堅定承諾,以及對營養保健品益處的日益認知,在有效的教育舉措、多樣化的健康產品和支持性監管環境的支持下,推動了市場主導地位。隨著對膳食補充劑的依賴不斷增加,它與更廣泛的整體健康運動一致,進一步鞏固了它們在日常生活中的重要地位。

市場競爭格局

該市場的主要全球參與者包括達能公司、哥蘭比亞公司、雀巢公司、拜耳公司、雅培營養品、GNC Holdings, LLC、Garden of Life、NOW Foods、Kellanova 和 Parry Nutraceuticals Limited。

俄羅斯-烏克蘭戰爭影響

俄羅斯-烏克蘭戰爭擾亂了供應鏈並導致原料價格波動,從而影響了全球營養保健品市場。主要農產品的短缺增加了成本並影響了供應。此外,地緣政治緊張局勢導致企業重新考慮採購策略,而消費者對健康和保健的興趣日益濃厚,推動了對營養保健品的需求。

按類型

草藥

蛋白質和胜肽

維生素和礦物質

益生元和益生菌

其他(脂肪酸和纖維)

按產品分類

功能性食品

穀物

麵包店和糖果店

乳製品

小吃

其他

功能性飲料

能量飲料

乳製品和乳製品替代飲料

果汁和蔬菜汁及飲料

非碳酸飲料

其他

膳食補充劑

平板電腦

液體

粉末

其他

個人護理

按來源

植物性

以動物為基礎

微生物

按配銷通路

超市/大賣場

便利商店

專賣店

藥局/藥房

網路零售店

其他

按申請

健康與保健

運動營養

臨床營養

按地區

北美洲

我們

加拿大

墨西哥

歐洲

德國

英國

法國

義大利

西班牙

歐洲其他地區

南美洲

巴西

阿根廷

南美洲其他地區

亞太

中國

印度

日本

澳洲

亞太其他地區

中東和非洲

主要進展

2024 年 9 月,Flore 推出了針對神經多樣性的益生菌系列,包括通路支持和情緒支持,專為自閉症譜系障礙 (ASD) 患者配製。這些產品是與亞利桑那州立大學合作開發的,基於一項臨床研究,該研究表明自閉症譜系障礙參與者經過三個月的治療後,胃腸道不適和認知能力得到顯著改善。

2024 年 6 月,Steadfast Nutrition 推出了三款新補充品:乳清蛋白、LIV Raw 和素食複合維生素大包裝(180 片)。這些產品滿足注重健康的個人和運動員的蛋白質和營養需求。這場發表會是在亞洲最大的健康健身盛會-國際健康運動健身節(IHFF)上舉行的。

2024 年 6 月,RSSL 推出了新的膳食補充劑測試服務,為客戶的研發、製造和供應鏈職能提供支援。該服務可確保可靠的周轉和高品質結果,提供營養測試、新成分評估和監管支援等分析,以有效滿足客戶的需求。

為什麼購買報告?

根據類型、產品、來源、配銷通路、應用和區域可視化全球營養保健品市場細分,並了解關鍵商業資產和參與者。

透過分析趨勢和共同開發來識別商業機會。

Excel 電子表格包含營養保健品市場的綜合資料集,涵蓋各個細分市場。

PDF 報告由詳盡的質性訪談和深入研究後的綜合分析組成。

產品映射以 Excel 形式提供,包含所有主要參與者的關鍵產品。

全球營養保健品市場報告將提供約 78 個表格、79 個圖表和 224 頁。

2024 年目標受眾

製造商/買家

產業投資者/投資銀行家

研究專業人員

新興公司

目錄

第 1 章:方法與範圍

第 2 章:定義與概述

第 3 章:執行摘要

第 4 章:動力學

  • 影響因素
    • 促進要素
      • 慢性病的增加
      • 創新的監管批准和增強的配方
    • 限制
      • 多樣化的監管框架
    • 機會
    • 影響分析

第 5 章:產業分析

  • 波特五力分析
  • 供應鏈分析
  • 定價分析
  • 監管分析
  • DMI 意見

第 6 章:按類型

  • 草藥
  • 蛋白質和胜肽
  • 維生素和礦物質
  • 益生元和益生菌
  • 其他(脂肪酸和纖維)

第 7 章:依產品

  • 功能性食品
    • 穀物
    • 麵包店和糖果店
    • 乳製品
    • 小吃
    • 其他
  • 功能性飲料
    • 能量飲料
    • 乳製品和乳製品替代飲料
    • 果汁和蔬菜汁及飲料
    • 非碳酸飲料
    • 其他
  • 膳食補充劑
    • 平板電腦
    • 液體
    • 粉末
    • 其他
  • 個人護理

第 8 章:按來源

  • 植物性
  • 以動物為基礎
  • 微生物

第 9 章:按配銷通路

  • 超市/大賣場
  • 便利商店
  • 專賣店
  • 藥局/藥房
  • 網路零售店
  • 其他

第 10 章:按申請

  • 健康與保健
  • 運動營養
  • 臨床營養

第 11 章:按地區

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 義大利
    • 西班牙
    • 歐洲其他地區
  • 南美洲
    • 巴西
    • 阿根廷
    • 南美洲其他地區
  • 亞太
    • 中國
    • 印度
    • 日本
    • 澳洲
    • 亞太其他地區
  • 中東和非洲

第 12 章:競爭格局

  • 競爭場景
  • 市場定位/佔有率分析
  • 併購分析

第 13 章:公司簡介

  • Danone SA
    • 公司概況
    • 產品組合和描述
    • 財務概覽
    • 主要進展
  • Glanbia plc
  • Nestle SA
  • Bayer AG
  • Abbott Nutrition
  • GNC Holdings, LLC
  • Garden of Life
  • NOW Foods
  • Kellanova
  • Parry Nutraceuticals Limited (*LIST NOT EXHAUSTIVE)

第 14 章:附錄

簡介目錄
Product Code: FB200

Report Overview

Global Nutraceuticals Market reached US$ 443.1 billion in 2023 and is expected to reach US$ 684.2 billion by 2031, growing with a CAGR of 5.58% during the forecast period 2024-2031.

Increasing consumer awareness about the benefits of a healthy lifestyle has led to greater demand for health supplements, particularly among aging populations who prioritize wellness. The rising incidence of lifestyle-related chronic diseases has also emphasized the need for preventive care through dietary choices. Additionally, the growth of e-commerce has made nutraceuticals more accessible to consumers, facilitating their purchase.

The market is poised for further expansion, with trends such as personalized nutrition based on individual genetic and lifestyle factors, a heightened focus on sustainability and ongoing innovation in product development. For instance, in July 2024, Renewtra has launched as a new brand in India's nutraceutical industry, aiming to revolutionize the market with its clinically proven, transparent-label products.

High rates of diabetes and obesity in US drive North America's dominance in the global nutraceuticals market. With approximately 37.3 million Americans having diabetes and over 41.9% of adults classified as obese, there is a growing demand for supplements and functional foods. As health-conscious consumers seek effective solutions, North America remains a leader in the nutraceutical industry.

Market Dynamics

Rise of Chronic Diseases

The frightening rise in obesity, diabetes and cardiovascular diseases (CVDs) is significantly driving the global nutraceutical market. With over 1 billion people affected by obesity and 537 million adults living with diabetes, the urgency for effective management solutions has never been clearer. Consumers are increasingly seeking nutraceutical products derived from food sources with health benefits that can help prevent or manage these chronic conditions.

The shift towards preventive health measures reflects a growing awareness of the critical link between diet and disease, prompting individuals to explore natural options that enhance well-being. Moreover, the rising health consciousness among consumers, fueled by concerns over chronic disease prevalence, is propelling the nutraceutical market forward.

Innovative Regulatory Approvals And Enhanced Formulations

The global nutraceutical market is driven by innovative regulatory approvals and enhanced formulations. In November 2022, Geno's launch of Avela natural (R)-1,3-Butanediol provides a sugar-free ingredient that elevates beta-hydroxybutyrate levels, enhancing mental clarity and athletic performance without requiring restrictive diets. Derived from plant sugars through sustainable fermentation, Avela aligns with the increasing consumer demand for natural products.

Additionally, regulatory approvals, such as the European Commission's endorsement of Carbopol Polymers, in October 2023, enable the creation of innovative, easier-to-swallow formulations. Together, these advancements cater to diverse consumer needs and preferences, driving the evolution of functional foods and positioning the nutraceutical market for sustained growth.

Diverse Regulatory Frameworks

The global nutraceuticals market faces significant restraints due to diverse regulatory frameworks. Each country has its classification criteria, considering different product perceptions from one region to another. This inconsistency complicates compliance, forcing companies to allocate time and resources to navigate various regulations. Additionally, strict marketing guidelines in some areas limit the health claims that can be made, hindering companies' ability to attract consumers.

Market Segment Analysis

The global nutraceuticals market is segmented based on type, product, source, distribution channel, application and region.

Superior Performance and Yield Potential of Hybrid Seeds

The plant-based segment dominates the global nutraceuticals market based on source. This is primarily due to the increasing consumer demand for natural and organic products, as well as growing awareness of the health benefits associated with plant-derived ingredients. Additionally, trends toward vegetarian and vegan diets contribute to the popularity of plant-based nutraceuticals.

The increasing number of vegans, estimated at around 88 million in 2022, significantly impacts the popularity of plant-based nutraceuticals. As more people adopt vegetarian and vegan diets, there's a growing demand for products that meet their nutritional needs without animal-derived ingredients. This trend is driving innovation and expansion in the plant-based sector, driving segment growth.

Market Geographical Share

Rising Health Consciousness Among North American Population

North America dominates the global nutraceuticals market. A high level of consumer awareness regarding wellness strongly supports North America's leadership in the worldwide market. The 2023 CRN Consumer Survey on Dietary Supplements reveals that 74% of US adults take dietary supplements, with 55% classified as regular users. This significant adoption enhances the vital role that supplements play in the daily health routines of Americans.

The widespread usage reflects a robust commitment to preventive health measures and a growing recognition of the benefits of nutraceuticals, driver market dominance, bolstered by effective education initiatives, a diverse range of product offerings health and a supportive regulatory environment. As reliance on dietary supplements continues to rise, it aligns with the broader movement towards holistic health, further solidifying their essential place in everyday life.

Market Competitive Landscape

The major global players in the market include Danone S.A., Glanbia plc, Nestle S.A., Bayer AG, Abbott Nutrition, GNC Holdings, LLC, Garden of Life, NOW Foods, Kellanova and Parry Nutraceuticals Limited.

Russia-Ukraine War Impact

The Russia-Ukraine war has impacted the global nutraceuticals market by disrupting supply chains and causing fluctuations in raw material prices. Shortages of key agricultural products have increased costs and affected availability. Additionally, geopolitical tensions have led companies to rethink sourcing strategies, while rising consumer interest in health and wellness has driven demand for nutraceuticals.

By Type

Herbals

Proteins & Peptides

Vitamins & Minerals

Prebiotics and Probiotics

Others (Fatty Acids and Fiber)

By Product

Functional Food

Cereal

Bakery and Confectionary

Dairy

Snack

Other

Functional Beverages

Energy Drinks

Dairy & Dairy Alternative Drinks

Fruit & Vegetable Juices and Drinks

Noncarbonated Drinks

Other

Dietary Supplements

Tablets

Liquid

Powder

Others

Personal Care

By Source

Plant-Based

Animal-Based

Microbial

By Distribution Channel

Supermarkets/Hypermarkets

Convenience Stores

Specialty Stores

Drug Stores/Pharmacies

Online Retail Stores

Other

By Application

Health and Wellness

Sports Nutrition

Clinical Nutrition

By Region

North America

US

Canada

Mexico

Europe

Germany

UK

France

Italy

Spain

Rest of Europe

South America

Brazil

Argentina

Rest of South America

Asia-Pacific

China

India

Japan

Australia

Rest of Asia-Pacific

Middle East and Africa

Key Developments

In September 2024, Flore launched a probiotic line for neurodiversity, including pathways support and mood support, formulated for individuals with autism spectrum disorder (ASD). Developed in collaboration with Arizona State University, these products were based on a clinical study that showed significant improvements in gastrointestinal discomfort and cognitive abilities among ASD participants after three months of treatment.

In June 2024, Steadfast Nutrition launched three new supplements: Whey Protein, LIV Raw and a vegetarian Multivitamin mega pack with 180 tablets. These products cater to the protein and nutrient needs of health-conscious individuals and athletes. The launch took place at the International Health Sports and Fitness Festival (IHFF), Asia's largest health and fitness event.

In June 2024, RSSL introduced a new dietary supplement testing service to support clients in R&D, manufacturing and supply chain functions. This service ensures reliable turnaround and quality results, offering analyses such as nutrition testing, novel ingredient evaluation and regulatory support to meet clients' needs efficiently.

Why Purchase the Report?

To visualize the global nutraceuticals market segmentation based on type, product, source, distribution channel, application and region, as well as understand key commercial assets and players.

Identify commercial opportunities by analyzing trends and co-development.

Excel spreadsheet containing a comprehensive dataset of the Nutraceuticals market, covering all levels of segmentation.

PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.

Product mapping available as excel consisting of key products of all the major players.

The global nutraceuticals market report would provide approximately 78 tables, 79 figures and 224 pages.

Target Audience 2024

Manufacturers/ Buyers

Industry Investors/Investment Bankers

Research Professionals

Emerging Companies

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

  • 3.1. Snippet by Type
  • 3.2. Snippet by Product
  • 3.3. Snippet by Source
  • 3.4. Snippet by Distribution Channel
  • 3.5. Snippet by Application
  • 3.6. Snippet by Region

4. Dynamics

  • 4.1. Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. Rise of Chronic Diseases
      • 4.1.1.2. Innovative Regulatory Approvals and Enhanced Formulations
    • 4.1.2. Restraints
      • 4.1.2.1. Diverse Regulatory Frameworks
    • 4.1.3. Opportunity
    • 4.1.4. Impact Analysis

5. Industry Analysis

  • 5.1. Porter's Five Force Analysis
  • 5.2. Supply Chain Analysis
  • 5.3. Pricing Analysis
  • 5.4. Regulatory Analysis
  • 5.5. DMI Opinion

6. By Type

  • 6.1. Introduction
    • 6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 6.1.2. Market Attractiveness Index, By Type
  • 6.2. Herbals
    • 6.2.1. Introduction
    • 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 6.3. Proteins & Peptides
  • 6.4. Vitamins & Minerals
  • 6.5. Prebiotics and Probiotics
  • 6.6. Others (Fatty Acids and Fiber)

7. By Product

  • 7.1. Introduction
  • 7.2. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
  • 7.3. Market Attractiveness Index, By Product
  • 7.4. Functional Food
    • 7.4.1. Introduction
    • 7.4.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
    • 7.4.3. Cereal
    • 7.4.4. Bakery and Confectionary
    • 7.4.5. Dairy
    • 7.4.6. Snack
    • 7.4.7. Other
  • 7.5. Functional Beverages
    • 7.5.1. Energy Drinks
    • 7.5.2. Dairy & Dairy Alternative Drinks
    • 7.5.3. Fruit & Vegetable Juices and Drinks
    • 7.5.4. Noncarbonated Drinks
    • 7.5.5. Other
  • 7.6. Dietary Supplements
    • 7.6.1. Tablets
    • 7.6.2. Liquid
    • 7.6.3. Powder
    • 7.6.4. Others
  • 7.7. Personal Care

8. By Source

  • 8.1. Introduction
  • 8.2. Market Size Analysis and Y-o-Y Growth Analysis (%), By Source
  • 8.3. Market Attractiveness Index, By Source
  • 8.4. Plant-Based
    • 8.4.1. Introduction
    • 8.4.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 8.5. Animal-Based
  • 8.6. Microbial

9. By Distribution Channel

  • 9.1. Introduction
  • 9.2. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
  • 9.3. Market Attractiveness Index, By Distribution Channel
  • 9.4. Supermarkets/Hypermarkets
    • 9.4.1. Introduction
    • 9.4.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 9.5. Convenience Stores
  • 9.6. Specialty Stores
  • 9.7. Drug Stores/Pharmacies
  • 9.8. Online Retail Stores
  • 9.9. Other

10. By Application

  • 10.1. Introduction
  • 10.2. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  • 10.3. Market Attractiveness Index, By Application
  • 10.4. Health and Wellness
    • 10.4.1. Introduction
    • 10.4.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 10.5. Sports Nutrition
  • 10.6. Clinical Nutrition

11. By Region

  • 11.1. Introduction
    • 11.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 11.1.2. Market Attractiveness Index, By Region
  • 11.2. North America
    • 11.2.1. Introduction
    • 11.2.2. Key Region-Specific Dynamics
    • 11.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 11.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
    • 11.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Source
    • 11.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
    • 11.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 11.2.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 11.2.8.1. US
      • 11.2.8.2. Canada
      • 11.2.8.3. Mexico
  • 11.3. Europe
    • 11.3.1. Introduction
    • 11.3.2. Key Region-Specific Dynamics
    • 11.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 11.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
    • 11.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Source
    • 11.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
    • 11.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 11.3.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 11.3.8.1. Germany
      • 11.3.8.2. UK
      • 11.3.8.3. France
      • 11.3.8.4. Italy
      • 11.3.8.5. Spain
      • 11.3.8.6. Rest of Europe
  • 11.4. South America
    • 11.4.1. Introduction
    • 11.4.2. Key Region-Specific Dynamics
    • 11.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 11.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
    • 11.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Source
    • 11.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
    • 11.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 11.4.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 11.4.8.1. Brazil
      • 11.4.8.2. Argentina
      • 11.4.8.3. Rest of South America
  • 11.5. Asia-Pacific
    • 11.5.1. Introduction
    • 11.5.2. Key Region-Specific Dynamics
    • 11.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 11.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
    • 11.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Source
    • 11.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
    • 11.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 11.5.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 11.5.8.1. China
      • 11.5.8.2. India
      • 11.5.8.3. Japan
      • 11.5.8.4. Australia
      • 11.5.8.5. Rest of Asia-Pacific
  • 11.6. Middle East and Africa
    • 11.6.1. Introduction
    • 11.6.2. Key Region-Specific Dynamics
    • 11.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 11.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
    • 11.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Source
    • 11.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
    • 11.6.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application

12. Competitive Landscape

  • 12.1. Competitive Scenario
  • 12.2. Market Positioning/Share Analysis
  • 12.3. Mergers and Acquisitions Analysis

13. Company Profiles

  • 13.1. Danone S.A.
    • 13.1.1. Company Overview
    • 13.1.2. Product Portfolio and Description
    • 13.1.3. Financial Overview
    • 13.1.4. Key Developments
  • 13.2. Glanbia plc
  • 13.3. Nestle S.A.
  • 13.4. Bayer AG
  • 13.5. Abbott Nutrition
  • 13.6. GNC Holdings, LLC
  • 13.7. Garden of Life
  • 13.8. NOW Foods
  • 13.9. Kellanova
  • 13.10. Parry Nutraceuticals Limited (*LIST NOT EXHAUSTIVE)

14. Appendix

  • 14.1. About Us and Services
  • 14.2. Contact Us